Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: 2020-10-27
Affiliations: 13
Go to article